Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by DAVID GRAHAM and YOSHIO YAMAOKA.
DAVID GRAHAM
Connection Strength
11.133
YOSHIO YAMAOKA
  1. Empiric H. pylori therapy-10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best. Transl Cancer Res. 2016 Dec; 5(Suppl 7):S1476-S1478.
    View in: PubMed
    Score: 0.600
  2. Helicobacter pylori virulence and cancer pathogenesis. Future Oncol. 2014 Jun; 10(8):1487-500.
    View in: PubMed
    Score: 0.504
  3. Helicobacter pylori virulence factor genotypes in children in the United States: clues about genotype and outcome relationships. J Clin Microbiol. 2010 Jul; 48(7):2550-1.
    View in: PubMed
    Score: 0.379
  4. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis. 2009 May; 10(2):77-84.
    View in: PubMed
    Score: 0.354
  5. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs. 2008; 68(6):725-36.
    View in: PubMed
    Score: 0.323
  6. Ethical considerations of comparing sequential and traditional anti Helicobacter pylori therapy. Ann Intern Med. 2007 Sep 18; 147(6):434-5.
    View in: PubMed
    Score: 0.317
  7. A report card to grade Helicobacter pylori therapy. Helicobacter. 2007 Aug; 12(4):275-8.
    View in: PubMed
    Score: 0.314
  8. One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm. Gut. 2007 Jul; 56(7):1021-3; author reply 1022-3.
    View in: PubMed
    Score: 0.312
  9. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006 Jun; 55(6):775-81.
    View in: PubMed
    Score: 0.280
  10. Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology. 2004 Apr; 126(4):1030-43.
    View in: PubMed
    Score: 0.249
  11. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002 Aug; 123(2):414-24.
    View in: PubMed
    Score: 0.222
  12. Clarifications regarding the 3' repeat region of the cagA gene in Helicobacter pylori and clinical outcome. J Clin Microbiol. 2001 Jun; 39(6):2369-70.
    View in: PubMed
    Score: 0.205
  13. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter. 2001 Jun; 6(2):116-24.
    View in: PubMed
    Score: 0.205
  14. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A. 2000 Jun 20; 97(13):7533-8.
    View in: PubMed
    Score: 0.192
  15. Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis. 2000 Jun; 181(6):2083-6.
    View in: PubMed
    Score: 0.191
  16. Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect. 2000 Feb; 124(1):91-6.
    View in: PubMed
    Score: 0.187
  17. Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter. 2000; 5 Suppl 1:S3-9; discussion S27-31.
    View in: PubMed
    Score: 0.186
  18. Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut. 1999 Dec; 45(6):804-11.
    View in: PubMed
    Score: 0.184
  19. CagA status and gastric cancer unreliable serological tests produce unreliable data. Gastroenterology. 1999 Sep; 117(3):745.
    View in: PubMed
    Score: 0.181
  20. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999 Jul; 37(7):2274-9.
    View in: PubMed
    Score: 0.179
  21. Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infection. Helicobacter. 2019 Jun; 24(3):e12583.
    View in: PubMed
    Score: 0.176
  22. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol. 1999 Mar; 52(3):215-8.
    View in: PubMed
    Score: 0.175
  23. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter. 1998 Dec; 3(4):241-53.
    View in: PubMed
    Score: 0.172
  24. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998 Sep; 3(3):145-51.
    View in: PubMed
    Score: 0.169
  25. Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018 Jan; 33(1):37-56.
    View in: PubMed
    Score: 0.162
  26. Helicobacter, Hygiene, Atopy, and Asthma. Front Microbiol. 2017; 8:1034.
    View in: PubMed
    Score: 0.155
  27. Helicobacter pylori as an oncogenic pathogen, revisited. Expert Rev Mol Med. 2017 03 21; 19:e4.
    View in: PubMed
    Score: 0.153
  28. Autophagy-related genes in Helicobacter pylori infection. Helicobacter. 2017 Jun; 22(3).
    View in: PubMed
    Score: 0.151
  29. Helicobacter pylori vacuolating cytotoxin and gastric cancer risk: reconsidered. Transl Cancer Res. 2016 Sep; 5(Suppl 3):S557-S560.
    View in: PubMed
    Score: 0.147
  30. Prostate stem cell antigen gene TT genotype and development of intestinal metaplasia in Helicobacter pylori infection. J Dig Dis. 2016 Jan; 17(1):20-7.
    View in: PubMed
    Score: 0.141
  31. Identification of the genes that contribute to lactate utilization in Helicobacter pylori. PLoS One. 2014; 9(7):e103506.
    View in: PubMed
    Score: 0.127
  32. Helicobacter pylori infection introduces DNA double-strand breaks in host cells. Infect Immun. 2014 Oct; 82(10):4182-9.
    View in: PubMed
    Score: 0.127
  33. Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cells. Helicobacter. 2012 Jun; 17(3):193-202.
    View in: PubMed
    Score: 0.108
  34. Role of Helicobacter pylori plasticity region genes in development of gastroduodenal diseases. J Clin Microbiol. 2012 Feb; 50(2):441-8.
    View in: PubMed
    Score: 0.106
  35. Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils. J Gastroenterol Hepatol. 2011 Nov; 26(11):1677-84.
    View in: PubMed
    Score: 0.105
  36. The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone. Infect Immun. 2012 Jan; 80(1):381-7.
    View in: PubMed
    Score: 0.105
  37. Paxillin is a novel cellular target for converging Helicobacter pylori-induced cellular signaling. Am J Physiol Gastrointest Liver Physiol. 2011 Oct; 301(4):G601-11.
    View in: PubMed
    Score: 0.103
  38. Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol. 2009 Nov; 47(11):3493-500.
    View in: PubMed
    Score: 0.091
  39. homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol. 2009 Oct; 47(10):3241-5.
    View in: PubMed
    Score: 0.091
  40. Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci. 2009 Nov; 100(11):2152-9.
    View in: PubMed
    Score: 0.090
  41. Relationship between Helicobacter pylori hopQ genotype and clinical outcome in Asian and Western populations. J Gastroenterol Hepatol. 2009 Mar; 24(3):462-8.
    View in: PubMed
    Score: 0.087
  42. Unreliability of results of PCR detection of Helicobacter pylori in clinical or environmental samples. J Clin Microbiol. 2009 Mar; 47(3):738-42.
    View in: PubMed
    Score: 0.087
  43. Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol. 2009 Jan; 11(1):70-82.
    View in: PubMed
    Score: 0.085
  44. Adherence, internalization, and persistence of Helicobacter pylori in hepatocytes. Dig Dis Sci. 2008 Sep; 53(9):2541-9.
    View in: PubMed
    Score: 0.082
  45. vacA i-region subtyping. Gastroenterology. 2008 Apr; 134(4):1267; author reply 1268.
    View in: PubMed
    Score: 0.081
  46. Disturbance of apoptosis and DNA synthesis by Helicobacter pylori infection of hepatocytes. Dig Dis Sci. 2008 Sep; 53(9):2532-40.
    View in: PubMed
    Score: 0.081
  47. Regulation of IL-18 in Helicobacter pylori infection. J Immunol. 2008 Jan 15; 180(2):1207-16.
    View in: PubMed
    Score: 0.081
  48. OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organization. Cell Microbiol. 2008 Apr; 10(4):1008-20.
    View in: PubMed
    Score: 0.080
  49. Contemplating the future without Helicobacter pylori and the dire consequences hypothesis. Helicobacter. 2007 Nov; 12 Suppl 2:64-8.
    View in: PubMed
    Score: 0.080
  50. Thoughts about populations with unexpected low prevalences of Helicobacter pylori infection. Trans R Soc Trop Med Hyg. 2007 Sep; 101(9):849-51.
    View in: PubMed
    Score: 0.078
  51. Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production. Cell Microbiol. 2007 Oct; 9(10):2457-69.
    View in: PubMed
    Score: 0.077
  52. Pattern of transcription factor activation in Helicobacter pylori-infected Mongolian gerbils. Gastroenterology. 2007 Mar; 132(3):1024-38.
    View in: PubMed
    Score: 0.075
  53. Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J Biol Chem. 2007 Mar 02; 282(9):6242-54.
    View in: PubMed
    Score: 0.075
  54. Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):49-58.
    View in: PubMed
    Score: 0.075
  55. Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res. 2006 May 15; 66(10):5111-20.
    View in: PubMed
    Score: 0.072
  56. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol. 2005 Nov; 21(6):653-9.
    View in: PubMed
    Score: 0.070
  57. Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun. 2005 Nov; 73(11):7602-12.
    View in: PubMed
    Score: 0.070
  58. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell. 2005 Oct; 16(10):4954-66.
    View in: PubMed
    Score: 0.068
  59. Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype. Scand J Gastroenterol. 2005 May; 40(5):530-9.
    View in: PubMed
    Score: 0.067
  60. Natural history of gastric mucosal cytokine expression in Helicobacter pylori gastritis in Mongolian gerbils. Infect Immun. 2005 Apr; 73(4):2205-12.
    View in: PubMed
    Score: 0.067
  61. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology. 2005 Apr; 128(4):833-48.
    View in: PubMed
    Score: 0.067
  62. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004 Oct; 9(5):453-9.
    View in: PubMed
    Score: 0.064
  63. The Helicobacter pylori restriction endonuclease-replacing gene, hrgA, and clinical outcome: comparison of East Asia and Western countries. Dig Dis Sci. 2004 Sep; 49(9):1551-5.
    View in: PubMed
    Score: 0.064
  64. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004 Sep; 53(9):1235-43.
    View in: PubMed
    Score: 0.064
  65. Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol. 2004 May; 42(5):2279-81.
    View in: PubMed
    Score: 0.063
  66. False negative urea breath tests with H2-receptor antagonists: interactions between Helicobacter pylori density and pH. Helicobacter. 2004 Feb; 9(1):17-27.
    View in: PubMed
    Score: 0.062
  67. Relation between seroreactivity to low-molecular-weight Helicobacter pylori-specific antigens and disease presentation. Clin Diagn Lab Immunol. 2003 Nov; 10(6):1025-8.
    View in: PubMed
    Score: 0.061
  68. Cyclooxygenase expression during Helicobacter pylori infection in Mongolian gerbils. Dig Dis Sci. 2003 Nov; 48(11):2139-46.
    View in: PubMed
    Score: 0.061
  69. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol. 2003 May; 98(5):1005-9.
    View in: PubMed
    Score: 0.058
  70. Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial. Am J Gastroenterol. 2023 07 01; 118(7):1184-1195.
    View in: PubMed
    Score: 0.058
  71. Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther. 2003 Jan; 17(2):193-200.
    View in: PubMed
    Score: 0.057
  72. NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite. Dig Dis Sci. 2002 Jan; 47(1):38-43.
    View in: PubMed
    Score: 0.053
  73. Citric acid-enhanced Helicobacter pylori urease activity in vivo is unrelated to gastric emptying. Aliment Pharmacol Ther. 2001 Nov; 15(11):1763-7.
    View in: PubMed
    Score: 0.053
  74. Isolation of Helicobacter pylori from sheep-implications for transmission to humans. Am J Gastroenterol. 2001 May; 96(5):1396-401.
    View in: PubMed
    Score: 0.051
  75. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020 12; 69(12):2093-2112.
    View in: PubMed
    Score: 0.049
  76. Helicobacter pylori. Med Clin North Am. 2000 Sep; 84(5):1125-36, viii.
    View in: PubMed
    Score: 0.049
  77. Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother. 2000 Aug; 44(8):2133-42.
    View in: PubMed
    Score: 0.048
  78. Marked differences in the frequency of microsatellite instability in gastric cancer from different countries. Am J Gastroenterol. 1999 Oct; 94(10):3034-8.
    View in: PubMed
    Score: 0.046
  79. Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology. 1999 Aug; 117(2):342-9.
    View in: PubMed
    Score: 0.045
  80. Interleukin-17C in Human Helicobacter pylori Gastritis. Infect Immun. 2017 10; 85(10).
    View in: PubMed
    Score: 0.040
  81. Toll-like Receptor 10 in Helicobacter pylori Infection. J Infect Dis. 2015 Nov 15; 212(10):1666-76.
    View in: PubMed
    Score: 0.034
  82. Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican Republic. Hum Pathol. 2015 Jan; 46(1):129-36.
    View in: PubMed
    Score: 0.032
  83. Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. World J Gastroenterol. 2014 Mar 28; 20(12):3343-9.
    View in: PubMed
    Score: 0.031
  84. CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection. J Immunol. 2013 Oct 01; 191(7):3838-46.
    View in: PubMed
    Score: 0.030
  85. Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J Infect Dis. 2011 Mar 01; 203(5):726-35.
    View in: PubMed
    Score: 0.025
  86. The peopling of the Pacific from a bacterial perspective. Science. 2009 Jan 23; 323(5913):527-30.
    View in: PubMed
    Score: 0.022
  87. An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007 Feb 22; 445(7130):915-918.
    View in: PubMed
    Score: 0.019
  88. Roles of virD4 and cagG genes in the cag pathogenicity island of Helicobacter pylori using a Mongolian gerbil model. Gut. 2005 May; 54(5):584-90.
    View in: PubMed
    Score: 0.017
  89. Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin-8 in MKN45 cells. J Clin Microbiol. 2004 Aug; 42(8):3518-24.
    View in: PubMed
    Score: 0.016
  90. Traces of human migrations in Helicobacter pylori populations. Science. 2003 Mar 07; 299(5612):1582-5.
    View in: PubMed
    Score: 0.014
  91. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother. 2000 Aug; 44(8):2214-6.
    View in: PubMed
    Score: 0.012
  92. Variability in the interpretation of microsatellite patterns with different electrophoretic conditions. Mol Pathol. 1999 Oct; 52(5):302-4.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.